Kimberly-Clark Acquisition of Kenvue Hits 99% Approval After Kenvue Shares Slide 15%
Kenvue shares declined in premarket trading, down around 15% over six months, and trade above key moving averages while showing overbought RSI. Kimberly-Clark shareholders approved the acquisition with 99% support, with closing expected in H2 2026.
1. Shareholder Approval Milestone
Kimberly-Clark shareholders cast about 99% of votes in favor of acquiring Kenvue, advancing the transaction toward a second-half 2026 closing. The deal, pending customary regulatory reviews, aims to integrate Kenvue’s health and wellness brands with Kimberly-Clark’s consumer portfolio.
2. Kenvue Stock Slide and Technical Indicators
Kenvue shares have dropped around 15% over the past six months and fell during premarket trading, yet trade 4.6% above their 20-day SMA and 10.7% above their 100-day SMA. An RSI of 73 indicates overbought conditions, suggesting potential for a near-term pullback.
3. Upcoming Earnings Estimates
Kenvue is scheduled to report fourth-quarter and full-year 2025 results on February 17, with analysts projecting EPS of $0.22 versus $0.26 a year ago and revenue of $3.70 billion, up from $3.66 billion. The stock carries a hold consensus and an average price target of $20.18.